You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Kidney conditions
  5. Chronic kidney disease

Sparsentan for treating primary IgA nephropathy

  • Technology appraisal guidance
  • Reference number: TA1074
  • Published:  25 June 2025
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Resource impact
  2. Guidance into practice

Tools and resources

Tools and resources to help you put the guidance into practice.

Resource impact

  • Resource impact summary report

  • Resource impact template (Excel 981 KB)

    Published:
    01 August 2025

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top